Pierre François Rigaux
Directeur Général chez Myocene SA
Profil
Pierre François Rigaux is the founder of CEFALY Technology SPRL, which was founded in 2004.
He is currently the Director at KiOmed Pharma SA and the Managing Director & Director at Myocene SA since 2020.
Postes actifs de Pierre François Rigaux
| Sociétés | Poste | Début |
|---|---|---|
KiOmed Pharma SA
 KiOmed Pharma SA Pharmaceuticals: MajorHealth Technology KiOmed Pharma SA develops pharmaceutical products. It offers animal-free, ultrapure chitosan-based breakthrough biomaterials for the development of safer and highly efficient therapeutic medical devices and implants for joint health, ophthalmology, tissue engineering and biosurgery. The company was founded by Francois Blondel and Yves Henrotin in 2015 and is headquartered in Herstal, Belgium. | Directeur/Membre du Conseil | - |
Myocene SA
 Myocene SA Information Technology ServicesTechnology Services Myocene SA is a sports technology company based in Liege, Belgium. Myocene uses patented algorithms to deliver fast, accurate, objective, and quantifiable measurements of muscle fatigue levels. The Belgian company's technology, which has been tested on almost one thousand sportspeople, combines muscle electrostimulation and force sensors to calculate an individual's muscle fatigue index in just two minutes. Myocene's devices are aimed at the entire professional and semi-professional sports market and provide an objective assessment of muscle fatigue levels, a key parameter in improving athletic performance. The company was founded in 2020 and Pierre François Rigaux has been the CEO of the company since 2020. | Directeur Général | 05/05/2020 |
Anciens postes connus de Pierre François Rigaux
| Sociétés | Poste | Fin |
|---|---|---|
CEFALY Technology SPRL
 CEFALY Technology SPRL Medical SpecialtiesHealth Technology CEFALY-Technology BVBA engages in the development, manufacture, and sale of migraine treating and preventing medical device. The company was founded by Pierre-Yves Muller and Pierre Fran?ois Rigaux in 2004 and is headquartered in Seraing, Belgium. | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
CEFALY Technology SPRL
CEFALY Technology SPRL Medical SpecialtiesHealth Technology CEFALY-Technology BVBA engages in the development, manufacture, and sale of migraine treating and preventing medical device. The company was founded by Pierre-Yves Muller and Pierre Fran?ois Rigaux in 2004 and is headquartered in Seraing, Belgium. | Health Technology |
KiOmed Pharma SA
KiOmed Pharma SA Pharmaceuticals: MajorHealth Technology KiOmed Pharma SA develops pharmaceutical products. It offers animal-free, ultrapure chitosan-based breakthrough biomaterials for the development of safer and highly efficient therapeutic medical devices and implants for joint health, ophthalmology, tissue engineering and biosurgery. The company was founded by Francois Blondel and Yves Henrotin in 2015 and is headquartered in Herstal, Belgium. | Health Technology |
Myocene SA
Myocene SA Information Technology ServicesTechnology Services Myocene SA is a sports technology company based in Liege, Belgium. Myocene uses patented algorithms to deliver fast, accurate, objective, and quantifiable measurements of muscle fatigue levels. The Belgian company's technology, which has been tested on almost one thousand sportspeople, combines muscle electrostimulation and force sensors to calculate an individual's muscle fatigue index in just two minutes. Myocene's devices are aimed at the entire professional and semi-professional sports market and provide an objective assessment of muscle fatigue levels, a key parameter in improving athletic performance. The company was founded in 2020 and Pierre François Rigaux has been the CEO of the company since 2020. | Technology Services |
